Bali-based specialty coffee company Expat. Roasters has launched a new packaging range to support their commitment to sustainability and is leading the way in Indonesia by executing strategies like this. Launched in December 2019, Expat. Roasters has swapped out the traditional 1kg plastic foil lined coffee bag to a 2kg reusable tins for the wholesale sector of their business. The pilot program will start within Bali with big plans to roll out across their entire customer database throughout … [Read more...] about Expat. Roasters leading the way in sustainable coffee packaging
Asia Food Journal
Comexi Consolidates Its Presence in Brazil with the Sale of an F2 MB Pressto Pamplastic
The Brazilian company has opted for the flexographic presswith Comexi gearless system in order to work with more safety, quality and productiv Comexi, a specialist in solutions for the printing industry and the conversion of flexible packaging, has consolidated its presence in Brazil after the sale of an F2 MB pressto Pamplastic Indústria de Embalagens Plásticas LTDA. The Brazilian company, which produces exclusive packaging based on the needs of each of its customers, became the fourth in … [Read more...] about Comexi Consolidates Its Presence in Brazil with the Sale of an F2 MB Pressto Pamplastic
AIM ImmunoTech Files three provisional patent applications surrounding Ampligen(R) for use against the SARS-like Wuhan 2019 Novel Coronavirus
Ampligen(R) obtained 100% survival rate at clinically achievable human dosage levels for SARS in animal experiments Ampligen key to proposed broad-spectrum ‘universal’ coronavirus vaccine AIM ImmunoTech Inc. (NYSE American:AIM) recently announced the filing of three provisional patent applications related to its drug candidate Ampligen in the company’s efforts toward joining the global health community in the fight against the deadly Wuhan coronavirus that has so far infected approximately … [Read more...] about AIM ImmunoTech Files three provisional patent applications surrounding Ampligen(R) for use against the SARS-like Wuhan 2019 Novel Coronavirus